# Catalent CTS, LLC - Inspection Records

Source: https://www.keypedia.com/companies/catalent-cts-llc/db17ec22-68a4-42be-86e9-4c1410a493a8

> Inspection records and compliance data for Catalent CTS, LLC in Kansas City, Missouri. Access full analysis and detailed observations.

---

## Details

- Name: Catalent CTS, LLC
- FEI Number: 3002929455
- City: Kansas City
- State: Missouri
- Country Name: United States
- Address Line 1: 10245 Hickman Mills Dr
- Zip Code: 64137
- Business Operations: API/FDF ANALYTICAL TESTING, PACK

## Related Documents

- [483 - Catalent CTS, LLC - 2026-03-23](https://www.keypedia.com/records/483/catalent-cts-llc/e035ad86-1c8c-497f-9708-ef17567cf7f4) — source: FDA, date: March 23, 2026
- [483 - Catalent CTS, LLC - 2026-03-23](https://www.keypedia.com/records/483/catalent-cts-llc/d4b76e88-3692-4b04-b3d6-e40964458e09) — source: FDA, date: March 23, 2026
- [FDA Inspection 1313380 - Catalent CTS, LLC - 2026-03-23](https://www.keypedia.com/records/fda_inspections/catalent-cts-llc/a5c24af1-2e0e-43c6-8650-afafc396197c) — source: FDA, date: March 23, 2026
- [FDA Inspection 1313380 - Catalent CTS, LLC - 2026-03-23](https://www.keypedia.com/records/fda_inspections/catalent-cts-llc/9e39460e-728f-4018-959b-5ce4e04ca6b6) — source: FDA, date: March 23, 2026
- [FDA Inspection 1165575 - Catalent CTS, LLC - 2022-03-04](https://www.keypedia.com/records/fda_inspections/catalent-cts-llc/b31b3536-baf7-4740-a854-af85f079c806) — classification: No Action Indicated (NAI), source: FDA, date: March 4, 2022
- [483 - Catalent CTS, LLC - 2018-10-23](https://www.keypedia.com/records/483/catalent-cts-llc/f0a4108f-c156-48cd-b380-4e63978fb25b) — source: FDA, date: October 23, 2018
- [FDA Inspection 1031493 - Catalent CTS, LLC - 2017-11-06](https://www.keypedia.com/records/fda_inspections/catalent-cts-llc/b2d29326-e4d9-4684-aba4-03e4a4a4cc8f) — classification: No Action Indicated (NAI), source: FDA, date: November 6, 2017
- [FDA Inspection 1031493 - Catalent CTS, LLC - 2017-11-06](https://www.keypedia.com/records/fda_inspections/catalent-cts-llc/ce5da55f-df3b-40a5-9c01-bcadb75dccec) — classification: No Action Indicated (NAI), source: FDA, date: November 6, 2017
- [FDA Inspection 932408 - Catalent CTS, LLC - 2015-06-29](https://www.keypedia.com/records/fda_inspections/catalent-cts-llc/92d3bfa4-fa36-4218-a40a-3467514898e7) — classification: No Action Indicated (NAI), source: FDA, date: June 29, 2015
- [FDA Inspection 932408 - Catalent CTS, LLC - 2015-06-29](https://www.keypedia.com/records/fda_inspections/catalent-cts-llc/9b93a73e-f1c4-4878-8836-09653e106864) — classification: No Action Indicated (NAI), source: FDA, date: June 29, 2015
- [483 - Catalent CTS, LLC - 2014-11-10](https://www.keypedia.com/records/483/catalent-cts-llc/5793ba1a-48e1-44ab-9e6e-522ce99e4293) — source: FDA, date: November 10, 2014
- [FDA Inspection 902815 - Catalent CTS, LLC - 2014-11-10](https://www.keypedia.com/records/fda_inspections/catalent-cts-llc/578ccffa-c9de-44da-87d0-b9034b40bf8c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 10, 2014
- [FDA Inspection 869225 - Catalent CTS, LLC - 2014-03-05](https://www.keypedia.com/records/fda_inspections/catalent-cts-llc/b70dadb2-1970-492f-b80c-d54b706acc03) — classification: No Action Indicated (NAI), source: FDA, date: March 5, 2014
- [FDA Inspection 815514 - Catalent CTS, LLC - 2013-01-14](https://www.keypedia.com/records/fda_inspections/catalent-cts-llc/72c27b13-db05-4e96-a54f-c4a6d6de1d06) — classification: No Action Indicated (NAI), source: FDA, date: January 14, 2013

## Related Companies

- [Ultradent Products, Inc.](https://www.keypedia.com/companies/ultradent-products-inc/16b4d8af-54bd-48d3-acc8-a5169bd5bfe3)
- [Lyne Laboratories, Inc.](https://www.keypedia.com/companies/lyne-laboratories-inc/47a79cbe-dd2e-43d9-bf70-129caae3817c)
- [Abraxis Bioscience, LLC](https://www.keypedia.com/companies/abraxis-bioscience-llc/5751a531-276f-4635-9289-30cacf498d86)
- [DPT Laboratories, Ltd](https://www.keypedia.com/companies/dpt-laboratories-ltd/0a6b4d0a-ad7e-4f4f-ab10-34e0ef9913d4)
- [Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company](https://www.keypedia.com/companies/bristol-myers-squibb-holdings-pharma-ltd-liability-company/64a65e7b-7328-491c-8b08-cc8f2e018968)
- [Bushu Pharmaceuticals Ltd.](https://www.keypedia.com/companies/bushu-pharmaceuticals-ltd/f3ccab51-b6fa-4873-b2de-61ba32d7967e)
- [Laboratorios Liconsa SAU](https://www.keypedia.com/companies/laboratorios-liconsa-sau/ab88a2bb-8c52-445d-8417-82ea8f48bdf6)
- [WES Pharma Inc.](https://www.keypedia.com/companies/wes-pharma-inc/26195242-bcfc-4382-817b-4d9d153b962d)
- [AMO (Hangzhou) Co., Ltd.](https://www.keypedia.com/companies/amo-hangzhou-co-ltd/00c065f6-3b50-4050-811e-d03ad3d646e9)
- [Resilience US, Inc.](https://www.keypedia.com/companies/resilience-us-inc/864cabb1-d73c-4706-8d04-3e5c2375f44e)

## Related Officers

- [Victoria A. Wagoner](https://www.keypedia.com/people/victoria-a-wagoner/3b26259b-4a87-485e-8fd5-b08aa87f6577)
- [Wayne D. Mcgrath](https://www.keypedia.com/people/wayne-d-mcgrath/42db5ab0-2e0b-4909-951c-e7621cd04f6e)
- [Investigator](https://www.keypedia.com/people/andrew-j-idzior/5b639c02-d062-4a5a-aa4a-8362ddfba2b6)
- [Matthew M. Schuckmann](https://www.keypedia.com/people/matthew-m-schuckmann/69dd0728-6b5d-41e7-834c-416e25a977dc)
- [Kelly M. Bromley](https://www.keypedia.com/people/kelly-m-bromley/964704be-b203-4c56-b1d7-6144e9e0236e)